Used in organic synthesis as a building block for pharmaceuticals, particularly in Suzuki-Miyaura cross-coupling reactions to form carbon-carbon bonds. Its boronic acid group enables coupling with aryl halides, making it valuable in the development of active pharmaceutical ingredients (APIs). The 2,4-difluoro-3-(cyclopentyloxy)phenyl structure enhances metabolic stability and binding affinity in drug candidates, especially in central nervous system and anti-inflammatory agents. Commonly employed in medicinal chemistry for lead optimization due to its favorable physicochemical properties and structural novelty.